Publications by authors named "Liuguan Liang"
Crit Rev Oncol Hematol
January 2024
Article Synopsis
- This article compares first-line treatment regimens for patients with HER2-negative advanced gastric cancer using a network meta-analysis of phase III trials.
- It analyzed data from a systematic review of 25 studies involving over 14,000 patients to evaluate the effectiveness and safety of various treatments.
- The findings suggest that a combination of sintilimab, capecitabine, and oxaliplatin (Sint-XELOX) offers the best overall and progression-free survival compared to other treatments like fluorouracil plus cisplatin (PF).
